MIAKALTSIK amp. 100 UI 1 ml. 5 amp
MIAKALTSIK amp. 100 UI 1 ml. 5 amp
The active substance is a synthetic salmon calcitonin.
The ingredients are glacial acetic acid, sodium acetate trihydrate, sodium chloride and phenol.
What is Miakaltsik injection or infusion and for what use?
Miakaltsik injection or infusion in the form of
Ampoules containing 100 IU / ml
How do Miakaltsik ampoules?
The substance belongs to the group of medicines known as calcitonin. Calcitonin is a hormone that is produced naturally by the body in humans and animals. Calcitonin regulates calcium levels in the blood. It is used to stop the process of bone loss and also suggested that it may help bone formation. Synthetic salmon calcitonin, the active substance is a form of the hormone, which is very powerful and has a lasting effect.
Miakaltsik used to treat osteoporosis. It is also used in conditions such as bone pain, bone Paget's disease and hypercalcemia.
Before using Miakaltsik injection or infusion:
Miakaltsik not take if you are allergic to calcitonin salmon or any of the ingredients listed at the beginning of this leaflet.
Use in elderly patients
There are no special requirements for the use of Miakaltsik and it can be used by the elderly
Use in children
Not recommended for use by children under 18 years.
Pregnant women should not use Miakaltsik
Breast-feeding women should not use Miakaltsik because there have been no studies in these patient groups.
Driving and operating machinery
Miakaltsik can cause fatigue, dizziness and vision changes that may impair your reactions
Important information about some of the ingredients of Miakaltsik:
In 1 ml of solution contains less than 23 mg of sodium, and therefore may be considered as beznatriev.
How to properly use Miakaltsik injection or infusion?
Solution in ampoules Miakaltsik usually administered in subcutaneous adipose tissue or muscle, usually in the thigh. Can be applied by injection or infusion into a vein.
The dose depends on the severity of the disease and how you respond to the drug. Your doctor will tell you how to use Miakaltsik. Do not exceed the prescribed dose.
You can make the following recommendations:
Osteoporosis: 50 to 100 IU daily or every other day administered by subcutaneous or intramuscular injection
Bone pain: 100 to 200 IU daily administered by intravenous saline infutsiya or by subcutaneous or intramuscular injection in divided doses covering the entire day until a satisfactory result.
Paget's disease: 100 IU daily or every other day, administered by subcutaneous or intramuscular injection.
Emergency treatment of hypercalcemic crisis: daily 5 to 10 IU per kilogram of body weight given by slow intravenous infusion or by intravenous injection divided into 2 to 4 doses throughout the day.
Prolonged treatment of chronic hypercalcemia: daily 5 to 10IU per kilogram body weight administered by subcutaneous or intramuscular injection in one or two divided doses. If Miakaltsik volume that needs to be injected exceeds 2 mL, it is recommended intramuscular dose may be divided into several doses and application sites to change.
If you inject yourself solution:
Inject only if clear and colorless. Do not inject if it seems unusual.
Do not give yourself the injection unless you believe you can do it.
Solution to reach room temperature before injecting.
POSSIBLE SIDE EFFECTS:
Miakaltsik can cause side effects
If you experience any of the following serious effects, immediately consult a doctor:
Severe allergic reactions occurring in the form of rash, rapid pulse, difficulty breathing, swollen throat or tightness in the chest.
Sudden life-threatening allergic reactions leading to low blood pressure or shock
Swelling of the face, limbs or whole body.
Other side effects:
Common - dizziness, headache, taste changes, sudden reddening of the face and / or neck, nausea, diarrhea, abdominal pain, pain in bones and joints, fatigue.
Uncommon - blurred vision, increased blood pressure, vomiting, pain in muscles, bones or joints, flu-like symptoms, swelling of the extremities.
Rare - allergic reactions, including redness of skin and itching, frequent urination, redness and swelling at the injection site.